Study Protocol and Baseline Cardiometabolic Characterization of the RIO-Study (Response to an Intervention with Omega-3): A Randomized, Double-Blind, Placebo-Controlled Crossover Trial on Lipid and Inflammatory Profiles in Overweight and Obese Adults with Hypertriglyceridemia in Valdivia, Chile
Authors:
- Josefina EnríquezJEJosefina Enríquez
- Consuelo QuezadaCQConsuelo Quezada
- Jessica MolinaJMJessica Molina
- Matías SáezMSMatías Sáez
- Iarela MitreIMIarela Mitre
- Camila MoreiraCMCamila Moreira
- Feren SandovalFSFeren Sandoval
- Rodrigo MaldonadoRMRodrigo Maldonado
- Montserrat FitóMFMontserrat Fitó
- Sebastián ZagmuttSZSebastián Zagmutt
- Catalina Ramírez-ContrerasCRCatalina Ramírez-Contreras
- Eneko GanuzaEGEneko Ganuza
Open Access
- 29 October 2025
- Vol. 17 (21) , 3397
Abstract
Background: Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide, with metabolic syndrome and its risk factors contributing substantially to cases in Latin America. In southern Chile, obesity, dyslipidemia, and sedentary behavior are highly prevalent, yet comprehensive baseline data on these factors are scarce. Establishing regional cardiometabolic profiles is crucial to inform prevention strategies. Objective: To describe the RIO-Study protocol and characterize the baseline cardiometabolic profile of adults from Valdivia, southern Chile. Methods: The RIO-Study is a randomized, double-blind, placebo-controlled, crossover clinical trial evaluating the effects of nutritional doses of seaweed-derived omega-3 fatty acids on lipid metabolism, inflammation, and molecular lipid regulators in adults with overweight/obesity. The protocol includes a standardized high-fat breakfast challenge and repeated postprandial blood sampling to assess dynamic lipid responses. Screening procedures comprised blood pressure measurement, fasting blood sampling, body composition by bioelectrical impedance, and health and lifestyle questionnaires. Results: Among screened participants, 91% presented overweight/obesity and 55% presented central adiposity, exceeding regional cardiometabolic risk thresholds (waist circumference ≥ 90 cm in men, ≥80 cm in women). Men exhibited higher waist circumference (100 ± 10.8 vs. 91.6 ± 11.9 cm), waist-to-hip ratio (0.99 ± 0.08 vs. 0.92 ± 0.07), systolic blood pressure (130 ± 12.0 vs. 122 ± 13.4 mmHg), triglycerides (168 ± 84.7 vs. 122 ± 64.9 mg/dL), VLDL-C (33.7 ± 17.2 vs. 24.4 ± 13.0 mg/dL), and sedentary time (8.1 ± 2.3 vs. 6.8 ± 2.3 h/day). Women had greater total body fat (39.7 ± 4.75% vs. 31.1 ± 5.30%), higher HDL-C (56.6 ± 13.3 vs. 46.9 ± 9.39 mg/dL), and more often had normal weight (13% vs. 0%). Conclusions: The RIO-Study provides novel insights into cardiometabolic risk and will elucidate the effects of nutritional omega-3 supplementation in a high-risk Chilean population.Keywords
Funding Information
- Fondo Nacional de Desarrollo Científico y Tecnológico (11241108)
This publication has 27 references indexed in Scilit:
- Triglyceride levels and its association with all-cause mortality and cardiovascular outcomes among patients with heart failureNature Communications, 2025
- Differences in Presentation, Diagnosis and Management of Heart Failure in Women. A Scientific Statement of the Heart Failure Association of the ESCEuropean Journal of Heart Failure, 2024
- Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveysActa Cardiologica, 2023
- Exploring the sequential accumulation of metabolic syndrome components in adultsScientific Reports, 2022
- Association between 24-h movement guidelines and cardiometabolic health in Chilean adultsScientific Reports, 2022
- Omega-3 fatty acids and inflammatory processes: from molecules to manBiochemical Society Transactions, 2017
- Atherogenic Dyslipidemia in Latin America: Prevalence, causes and treatmentInternational Journal of Cardiology, 2017
- Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomesEuropean Heart Journal, 2015
- Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-AnalysisCurrent Atherosclerosis Reports, 2011
- Postprandial lipemia and cardiovascular diseaseCurrent Atherosclerosis Reports, 2003